Effectiveness and Safety of Botulinum Toxin Type A in the Treatment of Androgenetic Alopecia

Table 1

Demographic and clinical characteristics.

	BTA ()	BTA+FNS ()	value
Age (years)			0.571
BMI (kg/m^2)			0.463
Age hair loss first noticed (years)			0.386
Disease duration (years)			0.596
Norwood-Hamilton grade, (%)
II vertex	9 (30.0)	7 (21.2)
III	13 (43.3)	15 (45.4)
IV	8 (26.7)	11 (33.3)	0.696
Hair counts before treatment (root/cm^2)			0.715

BTA: botulinum toxin type A; BTA+FNS: botulinum toxin type A+finasteride.